Search Results 401-410 of 18631 for crohn's disease

1. Victor G. Chedid, M.D., M.S. - Mayo Clinic Faculty Profiles

   The research of Victor G. Chedid, M.D., M.S., pertains to inflammatory bowel disease (IBD) including Crohn's disease and ulcerative colitis. He focuses on ...

2. Colon and Rectal Surgery - Overview - Mayo Clinic

   Inflammatory bowel disease — Crohn's disease and ulcerative colitis · Diverticulitis and diverticular disease; Anal problems such as hemorrhoids, fistula and ...

3. Edward V. Loftus, Jr., M.D. - Mayo Clinic Faculty Profiles

   Incidence and prevalence of Crohn's disease and ulcerative colitis. Unusual and unforeseen complications of inflammatory bowel disease. Clinical trials of ...

4. Gastritis - Symptoms and causes - Mayo Clinic

   ... Crohn's disease, celiac disease, sarcoidosis and parasitic infections. Complications. Left untreated, gastritis may lead to stomach ulcers and stomach bleeding.

5. A Study to Evaluate the Safety and Effectiveness of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

   Patients of either gender ≥ 18 years and ≤ 75 years of age. Patients with Crohn's Disease (CD) diagnosed at least 6 months prior to Screening visit in ...

6. William A. Faubion, Jr., M.D. - Doctors and Medical Staff - Mayo Clinic

   Inflammatory bowel disease (Crohn's disease/ulcerative colitis) · Pediatric to Adult care transition · Pediatric IBD clinical trials · Stem cell trials/research ...

7. Ulcerative colitis - Doctors and departments - Mayo Clinic

   This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms and treatment.

8. May 17, 2013 Contact: Brian Kilen 507-284-5005 (days) 507-284-2511 (evenings) Email: newsbureau@mayo.edu Mayo Clinic: Inflamma

   ROCHESTER, Minn. — Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic.

9. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease - Mayo Clinic

   ... and endoscopic response in participants with moderate to severe Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender ...

10. Infliximab-dyyb (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Infliximab-dyyb injection is used to reduce the symptoms of moderate to severe active Crohn's disease and ulcerative colitis in adults and children who have ...